Statins use and its impact in EGFR‐TKIs resistance to prolong the survival of lung cancer patients: A Cancer registry cohort study in Taiwan

Statins have been shown to be a beneficial treatment as chemotherapy and target therapy for lung cancer. This study aimed to investigate the effectiveness of statins in combination with epidermal growth factor receptor‐tyrosine kinase inhibitor therapy for the resistance and mortality of lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Phung‐Anh, Chang, Chih‐Cheng, Galvin, Cooper J., Wang, Yao‐Chin, An, Soo Yeon, Huang, Chih‐Wei, Wang, Yu‐Hsiang, Hsu, Min‐Huei, Li, Yu‐Chuan (Jack), Yang, Hsuan‐Chia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419042/
https://www.ncbi.nlm.nih.gov/pubmed/32441434
http://dx.doi.org/10.1111/cas.14493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419042/
https://www.ncbi.nlm.nih.gov/pubmed/32441434
http://dx.doi.org/10.1111/cas.14493

Ejemplares similares